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Cholestasis is defined as reduced bile 
flux, either caused by an obstruction of bile 
ducts or by compromised hepatocellular se-
cretion (Pollheimer et al., 2014; Fickert et al., 
2014; Slitt et al., 2007; Jansen et al., 2017). In 
the acute phase of obstructive cholestasis rup-
tures of the apical (bile canaliculi forming) 
hepatocyte membranes occur that lead to bile 
salt rich necrotic regions, the so-called bile in-
farcts (Ghallab et al., 2019). In the chronic 
phase, the biliary tree undergoes massive re-
modeling by branching of interlobular ducts 
and re-looping so that an initially sparse net-
work around portal veins transforms into a 
much denser network (Vartak et al., 2016). 
For a better understanding of the complex ar-
chitectural changes it is necessary to 3D-re-
construct and quantify the changes during 
cholestasis. For this purpose, Damle-Vartak 
and colleagues recently published a protocol 
to visualize the finest domains of the biliary 
network, bile canaliculi and interlobular 
ducts, based on immunofluorescence, 3D-
confocal imaging, surface reconstruction and 
quantitative morphometry (Damle-Vartak et 
al., 2019). The method is applicable to all 
types of liver injury and can be used for 
cleared tissue of approximately 500 µm thick 
sections.  
One important discovery made by this 
method is that the most upstream domain of 
the biliary tract, bile canaliculi, responds dif-
ferently to cholestasis than the more down-
stream interlobular ducts (Damle-Vartak et 
al., 2019). Bile canaliculi adopt wider diame-
ters and form spine-like protrusions; while the 
ducts undergo elongation, branching and 
looping to form a denser mesh without in-
creasing their diameters.  
Recently, much effort has been invested 
to gain a better understanding of cholestasis 
(Ehrlich and Glaser, 2018; Pradhan-Sundd et 
al., 2018; Sultan et al., 2018; Thompson et al., 
2018) and associated hepatotoxicity (Sezgin 
et al., 2018; Leist et al., 2017; Grinberg et al., 
2014; Godoy et al., 2013). Often, these stud-
ies require quantitative image analysis as a 
precondition for mathematical modeling 
(Hoehme et al., 2010, 2017; Hammad et al., 
2014; Schliess et al., 2014; Ghallab et al., 
2016). The just published protocols (Damle-
Vartak et al., 2019) offer excellent precondi-
tions to study the spatial responses of the bil-
iary tree and can in principle be applied to an-
alyze any 3D-conduit-like structure.  
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